Tarek Arraf

Dr. Tarek Arraf

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
TATarek Arraf
Tarek Arraf
JCJavier Chahuan
Javier Chahuan
Luisa BertinLuisa Bertin
Luisa Bertin
GLGianni Di Lecce
Gianni Di Lecce
ESEmma Sirinic
Emma Sirinic
ESEdoardo Vincenzo Savarino
Edoardo Vincenzo Savarino
Eosinophilic esophagitis (EoE) is a chronic, immune-mediated, non-IgE-mediated food allergy and a leading cause of dysphagia and food impaction in adults, with rising prevalence worldwide. Diagnosis requires ≥15 eosinophils per high-power field on esophageal biopsy after exclusion of other causes of gastrointestinal eosinophilia. Food allergens, principally milk, wheat, eggs, legumes and seafood, drive the inflammatory process, and treatment options include proton pump inhibitors, topical corticosteroids, biologic agents and endoscopic dilation for stricturing disease. Among these, dietary therapy is the only approach that removes the causative trigger rather than suppressing the inflammatory response, making drug-free, sustained remission achievable. Elemental diets achieve the highest histological remission rates but are poorly tolerated in practice; empiric elimination following a step-up strategy, starting with one or two foods and escalating in the absence of response, is more practical for most adults. Conventional allergy testing cannot reliably identify food triggers in EoE and is not recommended for this purpose. Reintroduction of the trigger food leads to relapse, making long-term adherence essential, and not all patients are suitable candidates: repeated endoscopy, dietary restriction, quality of life impact and the risk of avoidant restrictive food intake disorder (ARFID) are barriers that must be weighed before recommending this approach. This review summarizes the available dietary approaches in adult and adolescent EoE, covering empiric elimination strategies and their efficacy, allergy test-directed diets, patient selection, the role of diet alongside other treatments, and nutritional adequacy and adherence.

30 October 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
Luisa BertinLuisa Bertin
Luisa Bertin
APAndrea Pasta
Andrea Pasta
EFElena Formisano
Elena Formisano
ETEnrico Tettoni
Enrico Tettoni
CBCedric Van de Bruaene
Cedric Van de Bruaene
ESEdoardo Vincenzo Savarino
Edoardo Vincenzo Savarino
Ultra-processed foods (UPFs) provide more than half of daily energy intake in several high-income countries, and their consumption is increasing worldwide. Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic gastrointestinal conditions whose burden has grown alongside industrialized dietary patterns. Here, we summarize the epidemiological, mechanistic and clinical evidence linking UPF consumption to both conditions. Most prospective cohorts and meta-analyses associate higher UPF intake with incident Crohn’s disease, whereas associations with ulcerative colitis are weaker and inconsistent. In IBS, observational studies, including a large prospective cohort, suggest a modest, dose-dependent association with risk, although data are limited and the diagnostic criteria have recently changed with Rome V. Mechanistically, both disorders may converge on the intestinal microenvironment: in experimental models, emulsifiers alter microbial composition and metabolism, the mucus layer, epithelial barrier integrity and mucosal immune activation, and non-nutritive sweeteners alter microbial composition and epithelial barrier function, although human data are limited and causality has not been established. We also discuss IBS-like symptoms in quiescent IBD, dietary management in both conditions, and the main knowledge gaps, including exposure assessment, residual confounding and the need for adequately powered intervention trials.

13 January 2026 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
TATarek Arraf
Tarek Arraf
YGYuri Gorelik
Yuri Gorelik
FMFares Mazzawi
Fares Mazzawi
HAHalim Awadie
Halim Awadie
SBSuzan Banna
Suzan Banna
AKAmir Klein
Amir Klein
First surveillance colonoscopy (SC1) following piecemeal endoscopic mucosal resection (pEMR) is recommended at 3 to 6 months. We aimed to investigate whether delayed SC1 is associated with increased risk of recurrence. This was a retrospective analysis of a prospective cohort of patients undergoing pEMR for large non-pedunculated colorectal polyps (LNPCPs). Patients were categorized into standard SC1 (3–6 months) and delayed SC1 (> 6 months) groups. The primary endpoint was recurrence at SC1. Secondary outcomes included recurrence at second surveillance colonoscopy (SC2) and features of lesion recurrence. Subgroup analyses of very delayed SC1 and high-risk lesions were performed. Recurrence rates were also evaluated with propensity score matching (PSM). We analyzed 577 lesions (standard: 407, delayed: 170) with a median polyp size of 30 mm (interquatile range [IQR] 25–40). Median time to SC1 was 5 months (IQR 5–6) in the standard versus 9 months (IQR 7–13) in the delayed group (P < 0.01). There were no significant differences in SC1 recurrence rates between groups (6.4% versus 6.5% in the standard and delayed respectively, P = 1). At SC2, recurrence rate was also similar between groups (3.8% versus 8.8% respectively, P = 0.43). Recurrence rates did not differ significantly among the analyzed subgroups. Recurrence rates did not differ significantly among the analyzed subgroups or in the PSM analyses. No advanced recurrences were detected at SC1 or SC2. Delayed SC1 is not associated with increased recurrence rates. Complete resection can be anticipated for most lesions and SC1 at 1-year post resection may be sufficient.

13 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SPShay Perek
Shay Perek
MLMajd Lahham
Majd Lahham
TATarek Arraf
Tarek Arraf
NSNaama Sitri
Naama Sitri
KHKhalil Hamati
Khalil Hamati
ARAyelet Raz-Pasteur
Ayelet Raz-Pasteur
Background/Objectives: Pulmonary embolism (PE) remains a significant cause of cardiovascular mortality, with risk stratification being critical for optimizing treatment decisions. Heart rate variability (HRV), a measure of autonomic nervous system function, had been explored as a prognostic index in various cardiovascular conditions, yet has received limited investigation regarding PE prognosis. Our objective was to evaluate the prognostic value of ultra-short HRV indices, obtained at the emergency department (ED), in patients presenting with PE. Methods: A retrospective cohort study, conducted at Rambam Health Care Campus, Haifa, Israel. All eligible patients diagnosed with acute PE at the ED, between the years 2010 and 2012 were included. Further, a subgroup analysis was performed to differentiate between oncological (n = 118) and non-oncological (n = 115) patient populations. Ten-seconds electrocardiogram was used to compute ultra-short HRV indices, specifically SDNN (standard deviation of normal-to-normal RR intervals) and RMSSD (root mean square of successive differences). Multivariate logistic regression models were created to assess HRV’s independent predictive value for 30-day and 90-day mortality. In addition, a survival analysis was carried out utilizing Cox regression and Kaplan-Meier curves. Results: 233 patients (42% male; age 65 ± 17) were included in the analysis. Ultra-short HRV indices did not significantly correlate with short-term mortality. However, in non-oncological patients (n = 115), multivariate analysis demonstrated that higher SDNN (as a continuous variable), was independently associated with increased 90-day mortality (AOR 1.018, 95% CI 1.000–1.037; p = 0.044). In contrast, HRV showed no predictive value for mortality in oncological patients. In both the entire cohort and the non-oncological sub-group, Kaplan-Meier plots established statistically significant differences, with lower HRV indices correlating with worse survival. This finding is paradoxical. The issue of context-dependent HRV (i.e., based on ECG obtained during rapid shallow breathing, which reduces HRV on the one hand, but is possibly adaptive during an acute PE, to increase oxygen supply and prevent shock in the short run, on the other hand), may explain these findings. Conclusions: Ultra-short HRV shows some promise in short term risk stratification of non-oncological PE patients. As for oncological patients, HRV was not found to have short term prognostic relevance.